| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
540,054 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,092,104 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
787,587 |
|
|
| Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 22 of 35
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-09-19 |
4 |
AS |
$23.00 |
$230,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-08-10 |
4 |
OE |
$6.46 |
$231,824 |
D/D |
35,886 |
42,581 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-03-10 |
4 |
S |
$114.89 |
$232,201 |
I/I |
(2,021) |
36,258 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2012-11-07 |
4 |
S |
$47.00 |
$236,470 |
D/D |
(5,000) |
169,691 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2012-12-04 |
4 |
S |
$47.94 |
$239,692 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-09-25 |
4 |
AS |
$24.00 |
$240,000 |
D/D |
(10,000) |
6,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2011-08-02 |
4 |
S |
$30.23 |
$242,136 |
D/D |
(8,000) |
127,093 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2012-12-31 |
4 |
AS |
$48.62 |
$243,116 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-04-26 |
4 |
AS |
$82.44 |
$248,640 |
D/D |
(3,000) |
326,211 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2012-12-12 |
4 |
AS |
$50.00 |
$250,000 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-05-03 |
4 |
AS |
$16.70 |
$251,807 |
D/D |
(15,000) |
17,695 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-12-28 |
4 |
AS |
$84.04 |
$252,120 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2020-01-07 |
4 |
AS |
$84.46 |
$253,380 |
D/D |
(3,000) |
327,530 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-11-03 |
4 |
S |
$85.33 |
$256,002 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-12-26 |
4 |
AS |
$86.43 |
$259,290 |
D/D |
(3,000) |
327,530 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-01-07 |
4 |
AS |
$87.58 |
$262,740 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2021-04-22 |
4 |
OE |
$26.49 |
$264,900 |
D/D |
10,000 |
312,498 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2021-04-23 |
4 |
OE |
$26.49 |
$264,900 |
D/D |
10,000 |
312,498 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-12-24 |
4 |
AS |
$88.73 |
$266,193 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-01-18 |
4 |
AS |
$54.00 |
$270,000 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-02-21 |
4 |
AS |
$90.12 |
$270,360 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-05-12 |
4 |
D |
$59.30 |
$270,823 |
D/D |
(4,567) |
185,189 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
AS |
$90.55 |
$271,650 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-01 |
4 |
AS |
$36.00 |
$275,069 |
D/D |
(7,453) |
18,667 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2019-04-08 |
4 |
AS |
$91.27 |
$275,598 |
D/D |
(3,000) |
324,211 |
0 |
- |
|
853 Records found
|
|
Page 22 of 35 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
